HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology

Volumn 138, Issue 3, 2010, Pages 905-912

  Valenti, Luca ^a   Fracanzani, Anna Ludovica ^a   Bugianesi, Elisabetta ^b   Dongiovanni, Paola ^a   Galmozzi, Enrico ^a   Vanni, Ester ^b   Canavesi, Elena ^a   Lattuada, Ezio ^a   Roviaro, Giancarlo ^a   Marchesini, Giulio ^c   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepatic Fibrosis; hfe Gene; Iron Overload; Nonalcoholic Fatty Liver Disease

Indexed keywords

ALANINE AMINOTRANSFERASE; HFE PROTEIN; IRON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; GLUCOSE TOLERANCE; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; ITALY; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK ASSESSMENT; SIDEROSIS;

EID: 77249139227     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.013     Document Type: Article

References (36)

1. Valenti L., Rametta R., Dongiovanni P., et al. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57 (2008) 1355-1362
2. Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-455
3. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
4. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
5. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132 (2000) 112-117
6. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
7. Teli M.R., James O.F., Burt A.D., et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22 (1995) 1714-1719
8. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
9. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002) 134-140
10. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
11. Wilfred de Alwis N.M., and Day C.P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 27 (2007) 44-54
12. Valenti L., Fracanzani A.L., Dongiovanni P., et al. Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122 (2002) 274-280
13. Miele L., Beale G., Patman G., et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135 (2008) 282-291
14. Valenti L., Dongiovanni P., Piperno A., et al. α1-Antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology 44 (2006) 857-864
15. Moirand R., Mendler M.H., Guillygomarch A., et al. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?. J Hepatol 33 (2000) 1024-1026
16. Valenti L., Dongiovanni P., Fracanzani A.L., et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis 35 (2003) 172-178
17. Valenti L., Fracanzani A.L., Dongiovanni P., et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 102 (2007) 1251-1258
18. Bugianesi E., Manzini P., D'Antico S., et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39 (2004) 179-187
19. Ruddell R.G., Hoang-Le D., Barwood J.M., et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C ζ/nuclear factor κB-regulated signaling in rat hepatic stellate cells. Hepatology 49 (2009) 887-900
20. Dongiovanni P., Valenti L., Ludovica Fracanzani A., et al. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol 172 (2008) 738-747
21. Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352 (2005) 1769-1778
22. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 46 (2007) 1291-1301
23. George D.K., Goldwurm S., McDonald G.A., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114 (1998) 311-318
24. Valenti L., Dongiovanni P., Fracanzani A.L., et al. Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al. Diabetes Care 31 (2008) e18-e19
25. Chitturi S., Weltman M., Farrell G.C., et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36 (2002) 142-149
26. Nelson J.E., Bhattacharya R., Lindor K.D., et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 46 (2007) 723-729
27. Bedogni G., Bellentani S., Miglioli L., et al. The Fatty Liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6 (2006) 33
28. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
29. Scheuer P.G., Williams R., and Muir A.R. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 84 (1962) 53-64
30. Valenti L., Dongiovanni P., Fracanzani A.L., et al. HFE mutations in nonalcoholic fatty liver disease. Hepatology 47 (2008) 1794-1796
31. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 32 (2004) 131-138
32. Nelson J.E., Wilson L., Brunt E.M., et al. Hepatic iron deposition in reticuloendothelial cells but not hepatocytes is associated with more severe NASH: results from the NASH clinical research network. International BioIron Society meeting, Porto, Portugal 185 (2009) 2009
33. Wood M.J., Powell L.W., and Ramm G.A. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111 (2008) 4456-4462
34. Aigner E., Theurl I., Theurl M., et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 87 (2008) 1374-1383
35. Aigner E., Theurl I., Haufe H., et al. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology 135 (2008) 680-688
36. Sartori M., Andorno S., Pagliarulo M., et al. Heterozygous (β)-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c. Gut 56 (2006) 693-698